Sandra Gomez-Perez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sandra Gomez-Perez has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Cecily A. Byrne
Cancer Health Equity and Career Development Program University of Illinois Chicago Chicago Illinois USA
3 shared publications - Patricia Sheean
Loyola University Chicago, 2160 South First Avenue, Cuneo 439, Maywood, IL, 60153
3 shared publications - Lisa Tussing-Humphreys
Department of Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL 60612, USA
2 shared publications - Sarah J. Peterson
Department of Clinical Nutrition Rush University Medical Center Chicago Illinois USA
2 shared publications Yanyu Zhang
Rush University Medical Center, Rush Bioinformatics and Biostatistics Core, 1653 West Congress Parkway Chicago IL 60612, USA
2 shared publications- Adrian L. Smith
University of Oxford
1 shared publication
Latest Publications
- Open Access
- 15 July 2026
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 41 (4) , 1020-1047
Future of CT body composition research: Methodological discrepancies and advances
Body composition research utilizing computed tomography (CT) has increased over the past several decades as researchers use clinically acquired CT for opportunistic screening or the identification of phenotypes such as sarcopenia, myosteatosis, and sarcopenic obesity associated with various clinical outcomes. While there continues to be exciting work being done in CT body composition research, including the use of artificial intelligence (AI) to streamline the assessment of body composition, fundamental methodological discrepancies continue to hinder clinical integration. In this narrative review of studies published between 2022 and 2025, we describe newer approaches to normalize skeletal muscle measurements for differences in body size. We provide an overview of the heterogeneity in deriving currently published CT reference criteria for body composition quantity and quality in a limited subset of studies from published literature. We also summarize currently published thresholds from a limited subset of studies, including those most commonly cited, applied to define low muscle quantity or poor muscle composition and compare and contrast these values, as well as their derivation. Finally, we highlight emerging areas utilizing AI technologies and the integration of CT body composition assessment into clinical practice, and on the flip side, the lack of guidance on how this information will be implemented to achieve personalized nutrition care and improve clinical outcomes.
- 15 July 2026
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 41 (4) , 1020-1047
Open AccessFuture of CT body composition research: Methodological discrepancies and advances
Body composition research utilizing computed tomography (CT) has increased over the past several decades as researchers use clinically acquired CT for opportunistic screening or the identification of phenotypes such as sarcopenia, myosteatosis, and sarcopenic obesity associated with various clinical outcomes. While there continues to be exciting work being done in CT body composition research, including the use of artificial intelligence (AI) to streamline the assessment of body composition, fundamental methodological discrepancies continue to hinder clinical integration. In this narrative review of studies published between 2022 and 2025, we describe newer approaches to normalize skeletal muscle measurements for differences in body size. We provide an overview of the heterogeneity in deriving currently published CT reference criteria for body composition quantity and quality in a limited subset of studies from published literature. We also summarize currently published thresholds from a limited subset of studies, including those most commonly cited, applied to define low muscle quantity or poor muscle composition and compare and contrast these values, as well as their derivation. Finally, we highlight emerging areas utilizing AI technologies and the integration of CT body composition assessment into clinical practice, and on the flip side, the lack of guidance on how this information will be implemented to achieve personalized nutrition care and improve clinical outcomes.
- Open Access
Concordance of Computed Tomography Regional Body Composition Analysis Using a Fully Automated Open-Source Neural Network versus a Reference Semi-Automated Program with Manual Correction
Quick, efficient, fully automated open-source programs to segment muscle and adipose tissues from computed tomography (CT) images would be a great contribution to body composition research. This study examined the concordance of cross-sectional areas (CSA) and densities for muscle, visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and intramuscular adipose tissue (IMAT) from CT images at the third lumbar (L3) between an automated neural network (test method) and a semi-automatic human-based program (reference method). Concordance was further evaluated by disease status, sex, race/ethnicity, BMI categories. Agreement statistics applied included Lin’s Concordance (CCC), Spearman correlation coefficient (SCC), Sorensen dice-similarity coefficient (DSC), and Bland–Altman plots with limits of agreement (LOA) within 1.96 standard deviation. A total of 420 images from a diverse cohort of patients (60.35 ± 10.92 years; body mass index (BMI) of 28.77 ± 7.04 kg/m2; 55% female; 53% Black) were included in this study. About 30% of patients were healthy (i.e., received a CT scan for acute illness or pre-surgical donor work-up), while another 30% had a diagnosis of colorectal cancer. The CCC, SCC, and DSC estimates for muscle, VAT, SAT were all greater than 0.80 (>0.80 indicates good performance). Agreement analysis by diagnosis showed good performance for the test method except for critical illness (DSC 0.65–0.87). Bland–Altman plots revealed narrow LOA suggestive of good agreement despite minimal proportional bias around the zero-bias line for muscle, SAT, and IMAT CSA. The test method shows good performance and almost perfect concordance for L3 muscle, VAT, SAT, and IMAT per DSC estimates, and Bland–Altman plots even after stratification by sex, race/ethnicity, and BMI categories. Care must be taken to assess the density of the CT images from critically ill patients before applying the automated neural network (test method).
Open AccessConcordance of Computed Tomography Regional Body Composition Analysis Using a Fully Automated Open-Source Neural Network versus a Reference Semi-Automated Program with Manual Correction
Quick, efficient, fully automated open-source programs to segment muscle and adipose tissues from computed tomography (CT) images would be a great contribution to body composition research. This study examined the concordance of cross-sectional areas (CSA) and densities for muscle, visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and intramuscular adipose tissue (IMAT) from CT images at the third lumbar (L3) between an automated neural network (test method) and a semi-automatic human-based program (reference method). Concordance was further evaluated by disease status, sex, race/ethnicity, BMI categories. Agreement statistics applied included Lin’s Concordance (CCC), Spearman correlation coefficient (SCC), Sorensen dice-similarity coefficient (DSC), and Bland–Altman plots with limits of agreement (LOA) within 1.96 standard deviation. A total of 420 images from a diverse cohort of patients (60.35 ± 10.92 years; body mass index (BMI) of 28.77 ± 7.04 kg/m2; 55% female; 53% Black) were included in this study. About 30% of patients were healthy (i.e., received a CT scan for acute illness or pre-surgical donor work-up), while another 30% had a diagnosis of colorectal cancer. The CCC, SCC, and DSC estimates for muscle, VAT, SAT were all greater than 0.80 (>0.80 indicates good performance). Agreement analysis by diagnosis showed good performance for the test method except for critical illness (DSC 0.65–0.87). Bland–Altman plots revealed narrow LOA suggestive of good agreement despite minimal proportional bias around the zero-bias line for muscle, SAT, and IMAT CSA. The test method shows good performance and almost perfect concordance for L3 muscle, VAT, SAT, and IMAT per DSC estimates, and Bland–Altman plots even after stratification by sex, race/ethnicity, and BMI categories. Care must be taken to assess the density of the CT images from critically ill patients before applying the automated neural network (test method).
- 12 October 2021
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 46, 386-393
Comparison between handheld ultrasound and regional and whole-body dual energy x-ray absorptiometry (DXA) for body fat assessment
- 12 October 2021
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 46, 386-393
Comparison between handheld ultrasound and regional and whole-body dual energy x-ray absorptiometry (DXA) for body fat assessment
- 1 September 2021
- Published by Elsevier in Journal of the Academy of Nutrition and Dietetics
- Vol. 121 (9) , A24
Examining Inflammation in Women with Metastatic Breast Cancer With and Without Sarcopenia
- 1 September 2021
- Published by Elsevier in Journal of the Academy of Nutrition and Dietetics
- Vol. 121 (9) , A24
Examining Inflammation in Women with Metastatic Breast Cancer With and Without Sarcopenia
- 13 August 2021
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 190 (1) , 121-132
Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer
Purpose To examine the relationship between skeletal muscle (SM) and cancer-specific outcomes for women with estrogen receptor-negative (ER−) metastatic breast cancer (MBC). Methods For this retrospective cohort, females (≥ 18 years) with histologically confirmed ER− MBC and computerized tomography (CT) imaging were screened. Demographic, anthropometric, and clinical data were collected uniformly from the electronic medical record. CT images inclusive of the third lumbar region (L3) at diagnosis, 6 and 12 months, were used to classify sarcopenia (≤ 41 cm2/m2) and myosteatosis (< 41 or 33 Hounsfield Units, adjusted for body mass index (BMI)) and to evaluate changes in SM and total adipose tissue (TAT) over time. Kaplan–Meier curves, Cox Proportional Hazards (PH), and restricted mean survival time (RMST) estimates were generated to examine the relationship between sarcopenia and myosteatosis and time to tumor progression (TTP), treatment toxicity and 2-year survival, adjusting for covariates. Results Participants were 58.0 (15.0) years of age, ethnically diverse (55% non-Hispanic white, 31% Black, 11% Hispanic), post-menopausal (73%, n = 111), and classified as overweight (BMI 29.4 (7.6)). At diagnosis, 40% (n = 61) were sarcopenic, 49% had myosteatosis, and 28% (n = 42) had both. While Cox PH modeling and RMST analysis reveal no significant relationship between sarcopenia at diagnosis and 2-year survival (RMST difference − 1.6 (1.4) months, HR 1.35 (0.88–2.08)), these analyses support a significant, adverse association between myosteatosis at diagnosis and 2-year survival (RMST difference − 2.4 (1.5) months, HR 1.72 (1.09–2.72)). Incident sarcopenia was 11% (n = 5/45) and 2.5% (n = 1/40), respectively, while incident myosteatosis was 19% (n = 8/42) and 15% (n = 5/34) at 6 and 12 months, respectively. TTP and treatment toxicities did not appear to be related to diagnostic SM or body composition changes over time. Conclusion Targeted interventions initiated within the first year of diagnosis to preserve or improve SM quality seem warranted for women with ER−MBC.
- 13 August 2021
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 190 (1) , 121-132
Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer
Purpose To examine the relationship between skeletal muscle (SM) and cancer-specific outcomes for women with estrogen receptor-negative (ER−) metastatic breast cancer (MBC). Methods For this retrospective cohort, females (≥ 18 years) with histologically confirmed ER− MBC and computerized tomography (CT) imaging were screened. Demographic, anthropometric, and clinical data were collected uniformly from the electronic medical record. CT images inclusive of the third lumbar region (L3) at diagnosis, 6 and 12 months, were used to classify sarcopenia (≤ 41 cm2/m2) and myosteatosis (< 41 or 33 Hounsfield Units, adjusted for body mass index (BMI)) and to evaluate changes in SM and total adipose tissue (TAT) over time. Kaplan–Meier curves, Cox Proportional Hazards (PH), and restricted mean survival time (RMST) estimates were generated to examine the relationship between sarcopenia and myosteatosis and time to tumor progression (TTP), treatment toxicity and 2-year survival, adjusting for covariates. Results Participants were 58.0 (15.0) years of age, ethnically diverse (55% non-Hispanic white, 31% Black, 11% Hispanic), post-menopausal (73%, n = 111), and classified as overweight (BMI 29.4 (7.6)). At diagnosis, 40% (n = 61) were sarcopenic, 49% had myosteatosis, and 28% (n = 42) had both. While Cox PH modeling and RMST analysis reveal no significant relationship between sarcopenia at diagnosis and 2-year survival (RMST difference − 1.6 (1.4) months, HR 1.35 (0.88–2.08)), these analyses support a significant, adverse association between myosteatosis at diagnosis and 2-year survival (RMST difference − 2.4 (1.5) months, HR 1.72 (1.09–2.72)). Incident sarcopenia was 11% (n = 5/45) and 2.5% (n = 1/40), respectively, while incident myosteatosis was 19% (n = 8/42) and 15% (n = 5/34) at 6 and 12 months, respectively. TTP and treatment toxicities did not appear to be related to diagnostic SM or body composition changes over time. Conclusion Targeted interventions initiated within the first year of diagnosis to preserve or improve SM quality seem warranted for women with ER−MBC.
- 30 April 2021
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 37 (1) , 102-109
Prevalence of low computed tomography–measured skeletal muscle index and handgrip strength in a general medical population
Background Sarcopenia is defined as the loss of muscle mass and function and has been associated with worsened outcomes, including disability and mortality. The aim of this study was to describe the prevalence of sarcopenia in patients who had an abdominal computed tomography (CT) scan completed within 7 days of hospital admission. Methods A retrospective study was conducted. Adult patients admitted to either the general medical or surgical floor were included. Muscle function was assessed using handgrip strength (HGS, kg), completed within the first 48 hours of admission. Skeletal muscle index (SMI, kg/m2) at the third lumber region was calculated among patients who had an abdominal CT scan completed within 7 days of admission. Sarcopenia was identified by the combination of low SMI and HGS. The primary outcome was the percentage of patients diagnosed with sarcopenia. Results A total of 1318 patients were admitted; 11% (n = 141) had an abdominal CT scan completed within 7 days of admission. Only race and prevalence of malnutrition were different between patients who did and did not have a CT completed. The overall prevalence of sarcopenia was 13% (n = 18/141). Additionally, 39% of the sample was at risk for sarcopenia, with either low SMI (n = 13/141) or low HGS (n = 42/141). Conclusions Overall prevalence of sarcopenia was low, but more than one‐third of patients had either low SMI or low HGS. Minimal differences were observed between patients who did and did not have an abdominal CT scan completed upon admission.
- 30 April 2021
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 37 (1) , 102-109
Prevalence of low computed tomography–measured skeletal muscle index and handgrip strength in a general medical population
Background Sarcopenia is defined as the loss of muscle mass and function and has been associated with worsened outcomes, including disability and mortality. The aim of this study was to describe the prevalence of sarcopenia in patients who had an abdominal computed tomography (CT) scan completed within 7 days of hospital admission. Methods A retrospective study was conducted. Adult patients admitted to either the general medical or surgical floor were included. Muscle function was assessed using handgrip strength (HGS, kg), completed within the first 48 hours of admission. Skeletal muscle index (SMI, kg/m2) at the third lumber region was calculated among patients who had an abdominal CT scan completed within 7 days of admission. Sarcopenia was identified by the combination of low SMI and HGS. The primary outcome was the percentage of patients diagnosed with sarcopenia. Results A total of 1318 patients were admitted; 11% (n = 141) had an abdominal CT scan completed within 7 days of admission. Only race and prevalence of malnutrition were different between patients who did and did not have a CT completed. The overall prevalence of sarcopenia was 13% (n = 18/141). Additionally, 39% of the sample was at risk for sarcopenia, with either low SMI (n = 13/141) or low HGS (n = 42/141). Conclusions Overall prevalence of sarcopenia was low, but more than one‐third of patients had either low SMI or low HGS. Minimal differences were observed between patients who did and did not have an abdominal CT scan completed upon admission.
- Open Access
- 1 September 2020
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 19, 100611
Effects of taurocholic acid metabolism by gut bacteria: A controlled feeding trial in adult African American subjects at elevated risk for colorectal cancer
- 1 September 2020
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 19, 100611
Open AccessEffects of taurocholic acid metabolism by gut bacteria: A controlled feeding trial in adult African American subjects at elevated risk for colorectal cancer
- 15 October 2019
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 44 (3) , 419-424
Tutorial: A Step‐by‐Step Guide (Version 2.0) for Measuring Abdominal Circumference and Skeletal Muscle From a Single Cross‐Sectional Computed‐Tomography Image Using the National Institutes of Health ImageJ
Background: In patients with acute and chronic illness, depleted skeletal muscle (SM) mass, also referred to as sarcopenia, is a condition associated with an underlying disease process and adverse outcomes. Because of software upgrades and errors related to installation, clarifications and a revised tutorial were needed for calculating SM cross‐sectional area (CSA) using the National Institutes of Health (NIH) ImageJ.Methods: A pilot study was conducted to determine the usability of the tutorial version 2.0. Eight adults (≥18 years of age) who had no previous experience or background in body composition or computed‐tomography imaging and owned a personal laptop computer (Mac or PC) were included in the pilot study. Participants were tested on the completion of 4 tasks: (1) installation of software, (2) updating the software, (3) following revised tutorial (version 2.0), and (4) transferring information from the software to a spreadsheet for calculation of SM CSA.Results: All participants completed the tutorial and all assigned tasks, 4/4 (100%). However, 38% (3/8) of the participants made errors while cutting and pasting values from the ImageJ results box to a spreadsheet for calculating SM CSA.Conclusion: The tutorial version 2.0 was easy to follow and provided sufficient information for adults to install, update, and perform the steps of body composition for the NIH ImageJ software without major issues. Care should be taken when cutting and pasting results from the software as well as when using the Microsoft Excel spreadsheet for calculating SM CSA.
- 15 October 2019
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 44 (3) , 419-424
Tutorial: A Step‐by‐Step Guide (Version 2.0) for Measuring Abdominal Circumference and Skeletal Muscle From a Single Cross‐Sectional Computed‐Tomography Image Using the National Institutes of Health ImageJ
Background: In patients with acute and chronic illness, depleted skeletal muscle (SM) mass, also referred to as sarcopenia, is a condition associated with an underlying disease process and adverse outcomes. Because of software upgrades and errors related to installation, clarifications and a revised tutorial were needed for calculating SM cross‐sectional area (CSA) using the National Institutes of Health (NIH) ImageJ.Methods: A pilot study was conducted to determine the usability of the tutorial version 2.0. Eight adults (≥18 years of age) who had no previous experience or background in body composition or computed‐tomography imaging and owned a personal laptop computer (Mac or PC) were included in the pilot study. Participants were tested on the completion of 4 tasks: (1) installation of software, (2) updating the software, (3) following revised tutorial (version 2.0), and (4) transferring information from the software to a spreadsheet for calculation of SM CSA.Results: All participants completed the tutorial and all assigned tasks, 4/4 (100%). However, 38% (3/8) of the participants made errors while cutting and pasting values from the ImageJ results box to a spreadsheet for calculating SM CSA.Conclusion: The tutorial version 2.0 was easy to follow and provided sufficient information for adults to install, update, and perform the steps of body composition for the NIH ImageJ software without major issues. Care should be taken when cutting and pasting results from the software as well as when using the Microsoft Excel spreadsheet for calculating SM CSA.
- Open Access
Associations between Alternate Healthy Eating Index-2010, Body Composition, Osteoarthritis Severity, and Interleukin-6 in Older Overweight and Obese African American Females with Self-Reported Osteoarthritis
Osteoarthritis (OA) is a leading cause of immobility in the United States and is associated with older age, inflammation, and obesity. Prudent dietary patterns have been associated with disease prevention, yet little evidence exists describing diet quality (DQ) in older overweight or obese African American (AA) adults with OA and its relation to body composition. We conducted a secondary data analysis of a dataset containing alternate Healthy Eating Index-2010 (AHEI-2010), body composition, OA severity, and serum interleukin-6 (IL-6) data from 126 AA females (aged 60–87 years) with OA to examine the relationships between these variables. Our sample had poor DQ and reported having higher OA severity as measured by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Interleukin-6 was negatively correlated with AHEI-2010, and AHEI-2010 and the WOMAC physical function subcategory (WOMACpf) were significant predictors of IL-6 (odds ratio (OR): 0.95, 95% confidence interval (CI) 0.92–0.99 and 1.04, 95% CI 1.01–1.07, respectively, p < 0.05) but not body composition. In conclusion, AHEI-2010 and WOMACpf were significant predictors of inflammation (IL-6) and AHEI-2010 accounted for ~16% of the variation of IL-6 (inflammation) in this sample.
Open AccessAssociations between Alternate Healthy Eating Index-2010, Body Composition, Osteoarthritis Severity, and Interleukin-6 in Older Overweight and Obese African American Females with Self-Reported Osteoarthritis
Osteoarthritis (OA) is a leading cause of immobility in the United States and is associated with older age, inflammation, and obesity. Prudent dietary patterns have been associated with disease prevention, yet little evidence exists describing diet quality (DQ) in older overweight or obese African American (AA) adults with OA and its relation to body composition. We conducted a secondary data analysis of a dataset containing alternate Healthy Eating Index-2010 (AHEI-2010), body composition, OA severity, and serum interleukin-6 (IL-6) data from 126 AA females (aged 60–87 years) with OA to examine the relationships between these variables. Our sample had poor DQ and reported having higher OA severity as measured by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Interleukin-6 was negatively correlated with AHEI-2010, and AHEI-2010 and the WOMAC physical function subcategory (WOMACpf) were significant predictors of IL-6 (odds ratio (OR): 0.95, 95% confidence interval (CI) 0.92–0.99 and 1.04, 95% CI 1.01–1.07, respectively, p < 0.05) but not body composition. In conclusion, AHEI-2010 and WOMACpf were significant predictors of inflammation (IL-6) and AHEI-2010 accounted for ~16% of the variation of IL-6 (inflammation) in this sample.